Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells
Yu‐Chia Chen, Mamoru Takada, Aerica Nagornyuk, Wu Muhan, Hideyuki Yamada, Takeshi Nagashima, Masayuki Ohtsuka, Jennifer G. DeLuca, Steven M. Markus, Motoki Takaku, Aussie Suzuki
This study shows that inhibiting the p38-MK2 pathway enhances the effectiveness of microtubule inhibitors in breast cancer cells while sparing normal cells.
eLife · May 19, 2025Peer-reviewedCancer Biology